One (1) chewable tablet contains: Orchic Substance 50 mg Creatine monohydrate 50 mg Soy Protein 1500 mg L-Arginine 107 mg L-Isoleucine 72 mg L-Leucine 118 mg L-Lysine 98 mg L-Valine 76 mg L-Methionine 21 mg L-Threonine 60 mg L-Phenylalanine 76 mg L-Glutamic Acid 270 mg L-Tyrosine 52 mg L-Tryptophan 18 mg L- Histidine 40 mg L-Proline 78 mg Aspartic Acid 172 mg
The water molecule, H2O, is a dipole and is a neutral molecule
Composition without synthetic additives The recipes are based on "real" foods
Fat reduction depends heavily on caloric intake and activity level
78 The NLRP3 inflammasome, part of the nucleotide-binding domain and leucine-rich repeat protein family complex, is essential in the development of numerous infections and inflammatory disorders
(2) Alternative Pathway for Certain Antimicrobial Products For applications received for new technology add-on payments for certain antimicrobial products, beginning with FY 2021, if a technology is designated by FDA as a QIDP and received FDA marketing authorization, and, beginning with FY 2022, if a drug is approved under FDA's LPAD pathway and used for the indication approved under the LPAD pathway, it will be considered not substantially similar to an existing technology for purposes of new technology add-on payments and will not need to meet the requirement that it represent an advance that substantially improves, relative to technologies previously available, the diagnosis or treatment of Medicare beneficiaries
